Welcome to our dedicated page for 10X Capital Venture Acquisition Ii news (Ticker: VCXAU), a resource for investors and traders seeking the latest updates and insights on 10X Capital Venture Acquisition Ii stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect 10X Capital Venture Acquisition Ii's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of 10X Capital Venture Acquisition Ii's position in the market.
10X Capital Venture Acquisition Corp. II (Nasdaq: VCXAU) announced that starting October 1, 2021, holders of units sold in the IPO can separately trade Class A ordinary shares and warrants. The separated shares will trade under the symbols 'VCXA' and 'VCXAW' on Nasdaq, while unseparated units will continue under 'VCXAU.' This transition allows for more trading flexibility. The units were initially offered with Cantor Fitzgerald & Co. as the sole book-running manager, and the registration was approved by the SEC on August 10, 2021.
10X Capital Venture Acquisition Corp. II (Nasdaq: VCXAU) successfully closed its initial public offering, raising $200 million from the sale of 20 million units priced at $10.00 each. The units began trading on Nasdaq under the symbol VXCAU on August 11, 2021. Each unit comprises one Class A ordinary share and one-third of a redeemable warrant. The company, a blank-check entity, aims to merge with high-growth technology businesses across various sectors, including eCommerce and healthcare. Cantor Fitzgerald & Co. managed the offering, granting a 45-day option for underwriters to purchase additional units.
10X Capital Venture Acquisition Corp. II has announced the pricing of its initial public offering (IPO) of 20 million units at $10.00 per unit, to be listed on the Nasdaq under the symbol VCXAU starting August 11, 2021. Each unit comprises one Class A ordinary share and one-third of a redeemable warrant, with the whole warrant exercisable at $11.50 per share. The company aims to merge or acquire high-growth technology businesses across various sectors. Cantor Fitzgerald & Co. is the sole book-running manager and has a 45-day option for additional units.
